Literature DB >> 11143998

Morphometry of interstitial fibrosis.

E De Heer1, Y W Sijpkens, M Verkade, M den Dulk, A Langers, J Schutrups, J A Bruijn, L A van Es.   

Abstract

Several clinical studies have confirmed that histomorphometric changes in the tubulointerstitial compartment contain the best correlating parameters to predict the development of progressive renal insufficiency. The process of interstitial fibrosis is accompanied by an influx of inflammatory cells, up-regulation of fibrogenic cytokines such as transforming growth factor-beta and basic fibroblast growth factor, transient down-modulation of their antagonists, generation and proliferation of myofibroblasts, and, finally, by accumulation of interstitial collagens and proteoglycans. A careful morphometric analysis of interstitial fibrosis requires sensitive parameters through which the severity can be quantified and by which the progression into renal insufficiency can be predicted. We have addressed these issues by morphometric analysis of both human biopsies and by refining existing experimental models in the rat. Morphometric analysis was performed using a Zeiss microscope equipped with a full colour 3CCD camera and KS-400 image analysis software from Zeiss-Kontron. For studies with human material, biopsies were examined from patients with various renal diseases including patients with chronic allotransplant dysfunction. The development of interstitial fibrosis was correlated with clinical parameters. In experimental models, we analysed the interstitial composition and eventual glomerular alterations in rats with bovine serum albumin (BSA)-induced protein overload nephropathy and with human IgG-induced chronic serum sickness nephritis. Finally, we adapted and refined the model of ureter obstruction-induced interstitial fibrosis in the rat. For this purpose, custom-made titanium clips (S&T, Neuhaus, Switzerland) were implanted around the ureter in the abdomen of rats to obstruct the ureter without causing necrosis. The clips were removed at various time points after obstruction of the ureter (1-14 days). The subsequent remodelling of the interstitium was studied thereafter, in order to establish whether uraemia-induced interstitial fibrosis remains reversible at all times. In rat models, we have found that both protein overload-induced and serum sickness-induced interstitial fibrosis are accompanied by the development of focal and segmental glomerulosclerosis. Only in the ureter obstruction model did selective interstitial fibrosis develop, and remained reversible at all times studied. For the reliable assessment of interstitial fibrosis we have found that the best correlating parameters of interstitial fibrosis with renal function were: (i) the ratio of protein accumulation of TGF-beta-1 and its antagonist decorin; (ii) interstitial expression of smooth muscle alpha-actin; and (iii) accumulation of interstitial collagens (as determined by immunoperoxidase and by Sirius red staining).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11143998     DOI: 10.1093/ndt/15.suppl_6.72

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  The epidemiological association of altitude with chronic kidney disease: Evidence of protective effect.

Authors:  Nasrollah Ghahramani; Faris Ahmed; Ammar Al-Laham; Eugene J Lengerich
Journal:  Nephrology (Carlton)       Date:  2011-02       Impact factor: 2.506

Review 2.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

3.  Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1.

Authors:  Wei Guo; Hong Xu; Jing Chen; Yong Yang; Jia Wei Jin; Rui Fu; Hai Mei Liu; Xi Liang Zha; Zhi Gang Zhang; Wen Yan Huang
Journal:  Mol Cell Biochem       Date:  2006-10-17       Impact factor: 3.396

4.  Morphometric and visual evaluation of fibrosis in renal biopsies.

Authors:  Alton B Farris; Catherine D Adams; Nicole Brousaides; Patricia A Della Pelle; A Bernard Collins; Ellie Moradi; R Neal Smith; Paul C Grimm; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

5.  Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction.

Authors:  Osamu Togao; Shigehiro Doi; Makoto Kuro-o; Takao Masaki; Noriaki Yorioka; Masaya Takahashi
Journal:  Radiology       Date:  2010-04-20       Impact factor: 11.105

Review 6.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

7.  Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.

Authors:  Peng Hu; Jing Wang; Xue Qi Zhao; Bo Hu; Ling Lu; Yuan Han Qin
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

8.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.

Authors:  Maoyin Pang; Jagan Kothapally; Haiping Mao; Evelyn Tolbert; Murugavel Ponnusamy; Y Eugene Chin; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-29

Review 10.  Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples.

Authors:  Alton B Farris; Juan Vizcarra; Mohamed Amgad; Lee A D Cooper; David Gutman; Julien Hogan
Journal:  Histopathology       Date:  2021-03-08       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.